Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework - Chiotis, Konstantinos; Saint-Aubert, Laure; Boccardi, Marina; Gietl, Anton; Picco, Agnese; Varrone, Andrea; Garibotto, Valentina; Herholz, Karl; Nobili, Flavio; Nordberg, Agneta; Frisoni, Giovanni B.; Winblad, Bengt; et al. (Neurobiology of aging, 2017)
Keywords: 5-Phases; Alzheimer Disease - diagnostic imaging; Alzheimer Disease - metabolism; Alzheimer's disease; Amyloid; Biomarker; Biomarker-based diagnosis; Biomarkers; Cerebral Cortex - diagnostic imaging; Cerebral Cortex - metabolism; Clinical validity; Development; Early diagnosis; Humans; Internal Medicine; Ligands; Neuroimaging; Neurology; Positron emission tomography; Reproducibility of Results; Neuroimaging; 5-Phases; Biomarker; Early diagnosis; Development; Amyloid; Clinical validity; Alzheimer's disease; Positron emission tomography; Biomarker-based diagnosis